Latest News, Medical Research

CARDAMYST™ Now Approved Self-Administered Treatment

ARHI Advanced Research for Health Improvement Icon

Advanced Research for Health Improvement played a critical role in research that has resulted in CARDAMYST™ (etripamil) Nasal Spray, the First and Only FDA-Approved Self-Administered Treatment for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)

For more information, please read the following announcement from Milestone Pharmacuticals.

Milestone Pharmacuticals